Modi Ventures, a Houston, TX-based newly launched venture partnership investing in fund managers and founders building companies across Tech Bio, Life Sciences and AI, closed its inaugural $32m fund.
Tech+Bio Fund I will target innovative companies transforming business in Tech Bio, life science and healthcare AI.
Investments in funds include Khosla Ventures, Section 32, Artis Ventures, Draper Associates and Antler Global. Direct investments include:
Initial Investments by the Tech+Bio Fund I include
- Lapsi Health, A medical technology company that is screening, diagnosing, treating and monitoring in medicine through sound and auscultation (acquired from stethoscopes)
- Starling Medicine, A predictive technology platform for the early detection of bladder health issues
- Cyberdontics, Automated dental surgery using advanced imaging, AI and robotics
Founded by Sahir Ali, a researcher, scientist and technologist recognized as a thought leader in the precision medicine and AI space, Modi aims to invest into opportunities such as Tech Bio where companies are creating exponential technologies that can transform health and technology.
Andrew Yang, former presidential candidate and founder of Venture for America was named an advisor.
